Company Profile
- Stock Code
- ALNY
- ISIN Code
- US02043Q1076
- Currency
- US Dollar (USD)
- IPO Date
- 2004-05-28

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for hereditary transthyretin-mediated (hATTR) amyloidosis; AMVUTTRA for ATTR and hATTR amyloidosis; Leqvio for hypercholesterolemia; Qfitlia for...